top of page

Fund open for subscription

image.png

Marigold Maturation Fund K/S

The Marigold Maturation Fund seeks to invest capital in early-stage and promising biotech companies to generate attractive returns, regardless of economic cycles. To ensure this, the biotech projects that form the basis of potential biotech companies undergo a comprehensive selection process, due diligence, and maturation, thereby minimizing risk. MGI Investment Management aims to increase the likelihood of success by identifying potential challenges prior to making an investment. 

thumbnail_11_edited.jpg
shutterstock_2422913535.jpg

Marigold Maturation Fund 

image.png
image.png
image.png
image.png
image.png
image.png
image.png
image.png

Medical Biotechnology

Number of portfolio companies: 4-8

Hard Cap: DKK 600.000.000

No financial leverage in the fund or the companies

Expected return IRR: 20-25%

Distributions expected to begin in 3-5 years

Fund duration: 10 years

Minimum investment: DKK 750.000

MG request image.jpg

Are you interested in expanding your investment portfolio? Would you like to learn more about investment opportunities in biotechnology? 

Thank you for your order.

Request investor material here

MGI Investment Management ApS

Agern Allé 24

2970 Hørsholm

CVR 43867970

AIFM

MGI Investment Management ApS is registered with the Financial Supervisory Authority as a manager of alternative investment funds (AIFM)

FTID: 23321

Auditor

Sønderup I/S​

Authorized auditor 

CVR 31824559

Terms and conditions

© Marigold Innovation 2025

bottom of page